COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 822: Articles 8211-8220  | Next

Influenza infection in ferrets with SARS-CoV-2 infection history
de Melo, C. V. B., Peters, F., van Dijken, H., Lenz, S., van de Ven, K., Wijsman, L., Gommersbach, A., Schouten, T., van Kasteren, P. B., van den Brand, J. M. A., de Jonge, J.
10.1101/2022.03.22.485425 — Posted: 2022-03-24
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
Gonzalez-Dominguez, I., Martinez, J. L., Slamanig, S., Lemus, N., Liu, Y., Lai, T. Y., Carreno, J. M., Singh, G., Singh, G., Schotsaert, M., Mena, I., McCroskery, S., Coughlan, L., Krammer, F., Garcia-Sastre, A., Palese, P., Sun, W.
10.1101/2022.03.21.485247 — Posted: 2022-03-24
Clinical validation and the evaluation of a colorimetric SARS-CoV-2 RT-LAMP assay identify its robustness against RT-PCR
Erdem, M., Andac-Ozketen, A., Ozketen, A. C., Karahan, G., Tozluyurt, A., Palaz, F., Alp, A., Unal, S.
10.1101/2022.03.21.22271747 — Posted: 2022-03-23
Undiagnosed COVID-19 in households with a child with mitochondrial disease
Gordon-Lipkin, E. M., Marcum, C., Kruk, S., Thompson, E., Kelly, S. E. M., Kalish, H., Sadtler, K., McGuire, P.
10.1101/2022.03.21.22272358 — Posted: 2022-03-23
Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records
Horne, E. M., Hulme, W. J., Keogh, R. H., Palmer, T. M., Williamson, E. J., Parker, E. P., Green, A., Walker, V., Walker, A. J., Curtis, H., Fisher, L., MacKenna, B., Croker, R., Hopcroft, L., Park, R. Y., Massey, J., Morely, J., Mehrkar, A., Bacon, S., Evans, D., Inglesby, P., Morton, C. E., Hickman, G., Davy, S., Ward, T., Dillingham, I., Goldacre, B., Hernan, M. A., Sterne, J. A.
10.1101/2022.03.23.22272804 — Posted: 2022-03-23
Association of COVID-19 with risks of hospitalization and mortality from other disorders post-infection: A study of the UK Biobank
XIANG, Y., ZHANG, R., QIU, J., So, H.-C.
10.1101/2022.03.23.22272811 — Posted: 2022-03-23
The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial.
Nguyen, T. P., Do, Q., Phan, L. T., Anh, D. D., Khong, H., Dinh, D. V., Hoang, L. V., Nguyen, T. V., Pham, H. N., Chu, M. V., Nguyen, T. T., Le, T. M., Trang, T. T. N., Dinh, T. T., Vo, T. V., Vu, T. T., Nguyen, Q. B. P., Phan, V. T., Nguyen, L. V., Nguyen, G. T., Tran, P. M., Nghiem, T. D., Tran, T. V., Nguyen, T. G., Tran, T. Q., Nguyen, L. T., Do, A. T., Nguyen, D. D., Ho, S. A., Nguyen, V. T., Pham, D. T., Tran, H. B., Vu, S. T., Hoang, S. X., Do, T. M., Nguyen, X. T., Le, G. Q., Tran, T., Cao, T. M., Dao, H. M., Nguyen, T. T. T., Doan, U. Y., Le, V. T. T., Tran, L. P., Nguyen, N. M., Nguyen, N. T., Pham, H. T. T., Nguyen, Q. H., Pham, Q. D., Nguyen, H. T., Nguyen, H. L. K., Trang, N. V., Nguyen, L. A. T., Nguyen, L. T., Trinh, N. T. H., Le, L. T. K., Tran, V. T. B., Chu, M. T. N., Phan, M. H., Nguyen, H. T. H., Tran, V. T., Tran, M. T. N., Nguyen, T. T. T., Ha, P. T., Huynh, H. T., Nguyen, K. D., Ung, T. T., Duong, N. H. T., Doan, C. C., Do, S. M.
10.1101/2022.03.22.22272739 — Posted: 2022-03-23
SCENTinel 1.1 rapidly screens for COVID-19 related olfactory disorders
Hunter, S. R., Hannum, M. E., Pellegrino, R., O'Leary, M. A., Rawson, N. E., Reed, D. R., Dalton, P. H., Parma, V.
10.1101/2022.03.23.22272807 — Posted: 2022-03-23
Research on the Emotions of Uninfected People during the COVID-19 Epidemic in China
Chen, G., Yue, J.-J.
10.1101/2022.03.22.22272730 — Posted: 2022-03-23
Risk of death following SARS-CoV-2 infection or COVID-19 vaccination in young people in England: a self-controlled case series study
Nafilyan, V., Bermingham, C., Ward, I. L., Morgan, J., Zaccardi, F., Khunti, K., Stanborough, J., Banerjee, A.
10.1101/2022.03.22.22272775 — Posted: 2022-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).